Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 36 entries
View as:

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

Phase: N/A Priority: Normal
NCT ID: NCT06926842 Org: User:
Start: 04/22/25 End: 06/04/26 Due: 06/04/27

Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS

Phase: N/A Priority: Normal
NCT ID: NCT03905707 Org: User:
Start: 05/07/19 End: 10/31/26 Due: 10/31/27

Efficacy and Safety of Dasiglucagon for Treatment of Post-bariatric Hypoglycemia in Roux-en-Y Gastric Bypass (RYGB) Operated Adults

Phase: N/A Priority: Normal
NCT ID: NCT04824872 Org: User:
Start: 02/28/23 End: 02/28/23 Due: 02/28/24

A Research Study Looking at the Safety of Single Doses of ZP9830 and How it Works in the Body of Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06682975 Org: User:
Start: 11/12/24 End: 12/31/25 Due: 12/31/26

A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism

Phase: N/A Priority: Normal
NCT ID: NCT03777176 Org: User:
Start: 02/07/19 End: 10/05/20 Due: 10/05/21

The Long-term Effect on Intestinal Absorption and Safety of Treatment With Glepaglutide in Patients With Short Bowel Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04991311 Org: User:
Start: 08/10/21 End: 09/05/23 Due: 09/05/24

Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children

Phase: N/A Priority: Normal
NCT ID: NCT03667053 Org: User:
Start: 09/28/18 End: 06/28/19 Due: 06/28/20

A Bridging Trial to Compare the PK Profile When Glepaglutide is Administered Via Vial/Syringe Versus Autoinjector.

Phase: N/A Priority: Normal
NCT ID: NCT04318743 Org: User:
Start: 03/04/20 End: 06/10/21 Due: 06/10/22

A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03378635 Org: User:
Start: 12/07/17 End: 05/25/18 Due: 05/25/19

Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial

Phase: N/A Priority: Normal
NCT ID: NCT04881825 Org: User:
Start: 06/16/21 End: 04/30/25 Due: 04/30/26

A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial Participants

Phase: N/A Priority: Normal
NCT ID: NCT05096598 Org: User:
Start: 10/19/21 End: 01/12/23 Due: 01/12/24

ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon

Phase: N/A Priority: Normal
NCT ID: NCT02916251 Org: User:
Start: 12/01/16 End: 04/05/17 Due: 04/05/18

Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03279302 Org: User:
Start: 09/04/17 End: 12/18/17 Due: 12/18/18

Single Ascending Doses of ZP4207 Administered in HV and in T1D to Evaluate Safety, Tolerability PKs and PDs of ZP4207 Compared to a Comparator

Phase: N/A Priority: Normal
NCT ID: NCT02367053 Org: User:
Start: 12/31/14 End: 04/30/15 Due: 04/30/16

Feasibility Trial Testing the Bionic Pancreas With ZP4207

Phase: N/A Priority: Normal
NCT ID: NCT02971228 Org: User:
Start: 11/30/16 End: 06/07/17 Due: 06/07/18

A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM

Phase: N/A Priority: Normal
NCT ID: NCT03895697 Org: User:
Start: 03/26/19 End: 07/30/19 Due: 07/30/20

Pharmacokinetic Profile of Glepaglutide After a Single Injection in Subjects With Varying Degrees of Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT04178447 Org: User:
Start: 12/10/19 End: 07/14/20 Due: 07/14/21

A Phase 2 Trial Testing ZP1848 in Patients With SBS

Phase: N/A Priority: Normal
NCT ID: NCT02690025 Org: User:
Start: 02/29/16 End: 05/31/17 Due: 05/31/18

A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

Phase: N/A Priority: Normal
NCT ID: NCT06000891 Org: User:
Start: 09/15/23 End: 03/21/25 Due: 03/21/26

Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV Administration

Phase: N/A Priority: Normal
NCT ID: NCT03735225 Org: User:
Start: 11/07/18 End: 06/24/19 Due: 06/24/20

A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05613387 Org: User:
Start: 11/07/22 End: 06/13/24 Due: 06/13/25

Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism

Phase: N/A Priority: Normal
NCT ID: NCT04172441 Org: User:
Start: 06/19/20 End: 03/07/22 Due: 03/07/23

Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM

Phase: N/A Priority: Normal
NCT ID: NCT03688711 Org: User:
Start: 11/01/18 End: 03/11/19 Due: 03/11/20

Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism

Phase: N/A Priority: Normal
NCT ID: NCT03941236 Org: User:
Start: 05/01/19 End: 12/31/26 Due: 12/31/27

A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03216226 Org: User:
Start: 06/28/17 End: 02/13/18 Due: 02/13/19